Blog
Prostate Cancer Screening by Age: What the USPSTF Says
The US Preventive Services Task Force says PSA screening is an individual decision for men aged 55 to 69 after talking with a clinician, and recommends against it for men 70 and older. It lists false positives, biopsy complications, overdiagnosis and overtreatment as harms. An update is in progress.
Written by the Prostadine label deskUpdated · 4 min read
The basics01
What do the grades mean?
Grade C means the Task Force recommends offering the service to selected patients, depending on circumstances, because the net benefit is small. Grade D means it recommends against the service.
For men 55 to 69, PSA-based screening is graded C: an individual decision after discussing benefits and harms with a clinician. For men 70 and older, it is graded D (USPSTF, Prostate cancer screening).
The Task Force notes that an update is in progress, so the grades may change. Check the current version with your doctor.
The evidence02
By age band
| Age | Grade | Meaning |
|---|---|---|
| Under 55 | Not graded here | Discuss with a doctor if you have risk factors |
| 55 to 69 | C | Individual decision after discussion (USPSTF, Prostate cancer screening) |
| 70 and older | D | Recommends against screening (USPSTF, Prostate cancer screening) |
The numbers03
What are the harms?
False positives, in which a raised PSA leads to tests that find nothing. Biopsy complications, such as bleeding, infection and pain. Overdiagnosis, which is finding a cancer that would never have caused symptoms or shortened life. Overtreatment, which is treating such a cancer and causing side effects such as urinary leakage and erectile problems (USPSTF, Prostate cancer screening).
These harms are why the guidance is cautious and why the choice sits with the man and his doctor.
The catch04
What is the possible benefit?
Finding an aggressive cancer early, when treatment may be more effective. Some studies suggest a small reduction in deaths from prostate cancer among screened men, and the size of that benefit is debated. The Task Force found it small for the 55 to 69 group, which is why it is an individual choice (USPSTF, Prostate cancer screening).
Safety05
How to decide
Know your risk
Family history, race and health matter.
Learn the harms and benefits
Ask the doctor to explain in numbers.
Say what matters to you
Some men value early detection above all, others value avoiding treatment side effects.
Decide, and revisit
The choice can change with time and with updated guidance.
What to do06
Where do supplements fit?
They do not. A prostate supplement is not a screening tool and does not lower cancer risk. Using one to feel safe, in place of the conversation above, is the wrong swap. Read our checkups guide and the doctor visit guide before the appointment.
On the label07
Family history and risk
Having a father or brother with prostate cancer raises a man's own risk, and doctors may suggest discussing screening earlier. Black men face higher rates in many countries, and that also shapes advice. The NCI notes that such factors are part of the discussion (NCI, PSA test).
None of this makes screening automatic. It means the conversation with a clinician should happen with the facts of your family on the table, so the choice fits you and not an average.
In practice08
Questions to ask at the appointment
Ask what the benefits and harms are for a man of your age and health. Ask what a positive result would lead to, and what you would do with a negative one. Ask how often to repeat the test, and whether a past result should be kept for comparison.
Ask also how the medicines you take might alter the result. Doctors hear these questions often, and a clear answer helps you decide without pressure from anyone, including from an advert.
The basics09
After the decision
Whatever you decide, write it down with the date and the reason. Guidance changes, health changes and wishes change, so the decision is worth a fresh look every year or two. A man who chose not to screen at 56 may choose differently at 62, and that is a perfectly reasonable thing to do.
Keep the notes with your other health papers, and share them with any new doctor you see so the conversation does not start from scratch.
FAQ10
Prostadine questions people ask
At what age should men consider PSA screening?
The USPSTF says 55 to 69 is an individual decision after a talk with a clinician. Men with a family history may start the conversation earlier.
Why does the USPSTF advise against screening after 70?
Because harms such as overdiagnosis and overtreatment tend to outweigh benefits in older men. Individual health and wishes still matter, so talk to your doctor.
What does overdiagnosis mean?
Finding a cancer that would never have caused symptoms or shortened life. It can lead to treatment with side effects and no benefit.
Is the guidance final?
No. The Task Force says an update is in progress. Ask your doctor for the current advice.
Who wrote this11
Written and reviewed by
Pages built from the bottle photos, the info page and linked NIH, FDA, NCI, FTC and peer-reviewed sources.
Last updated . Read our editorial standards and how we check reviews. This website is run by a licensed U.S. retail desk for Prostadine, not by the manufacturer. We earn money when you buy through our order links.
Keep reading
More about Prostadine
Licensed U.S. retail desk — Prostadine
Ready to try Prostadine?
Check your medicines first, then pick a pack. Three or six bottles ship free in the US and cost less per bottle, and every pack carries the 60-day money-back guarantee.
- Secure checkout
- 60-day money-back guarantee
- Ships from the U.S., free on 3 or 6
